Paradigm BioCapital is an investment firm focused on investing in transformative therapeutics.

Paradigm BioCapital

Amazon

reCAPTCHA

Microsoft Exchange Online

Office 365 Mail

Microsoft Azure DNS

GoDaddy DNS

Mimecast

Backstop Solutions Group

Finance and Administration

Jason Ku Wang

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Tourmaline Bio is a clinical biotechnology company developing transformative medicines to dramatically improve and prevent immune diseases.

Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.

Investors Active in East Coast (Top 10K)

Investors Active in Massachusetts

Late Stage Venture Investors with Investments in New York, New York

United States Late Stage Venture Investors

Paradigm BioCapital Advisors is an investment firm.

New York

United States

North America

Paradigm BioCapital Advisors

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 11, 2024 10:45 PM	a080f705
news daily refresh	general	Aug 12, 2024 6:00 AM	40294d2e
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 12, 2024 7:09 AM	46fa59a7
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:09 AM	ad4f5acd
crunchbase profile	general	Nov 25, 2024 9:47 AM	c86d8f7d
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:04 PM	6c0badae
peers	general	Jul 11, 2024 10:45 PM	3cfa346a
news basic	general	Jul 11, 2024 10:45 PM	860dd382
bundesanzeiger	filings
financials download nd	financials
private financials	financials

PARA

COM:PARADIGMBIOCAPITAL

Paradigm BioCapital